Melatonin-Mediated Cytoprotection against Hyperglycemic Injury in Müller Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Jiang, Tingting ^a   Chang, Qing ^a   Zhao, Zhenyang ^a,b   Yan, Saimei ^a   Wang, Ling ^a   Cai, Jiyang ^b   Xu, Gezhi ^a  

^a FUDAN UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTATHIONE; HEME OXYGENASE 1; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MESSENGER RNA; PROTEIN KINASE B; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG MECHANISM; ENZYME ACTIVATION; HORMONE ACTION; HYPERGLYCEMIA; IN VITRO STUDY; INTRACELLULAR SIGNALING; MUELLER CELL; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RECEPTOR UPREGULATION; RETINA INJURY;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; HYPERGLYCEMIA; MELATONIN; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84870744473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050661     Document Type: Article

References (48)

1. Frank RN, (2004) Diabetic retinopathy. N Engl J Med 350: 48-58.
2. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, et al. (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) 18: 963-983.
3. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. (1998) Diabetic retinopathy. Diabetes Care 21: 143-156.
4. Nicholson BP, Schachat AP, (2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Klin Exp Ophthalmol 248: 915-930.
5. Salam A, Mathew R, Sivaprasad S, (2011) Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmol 89: 405-411.
6. Porta M, Allione A, (2004) Current approaches and perspectives in the medical treatment of diabetic retinopathy. J Pharmacol Pharmacother 103: 167-177.
7. Wang J, Xu X, Elliott MH, Zhu M, Le YZ, (2010) Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59: 2297-2305.
8. Bai Y, Ma JX, Guo J, Wang J, Zhu M, et al. (2009) Muller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol 219: 446-454.
9. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, et al. (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19: 442-455.
10. Madsen-Bouterse SA, Kowluru RA, (2008) Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 9: 315-327.
11. Stehle JH, Saade A, Rawashdeh O, Ackermann K, Jilg A, et al. (2011) A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 51: 17-43.
12. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, et al. (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36: 1-9.
13. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ, (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1: 57-60.
14. Galano A, Tan DX, Reiter RJ, (2011) Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 51: 1-16.
15. Jou MJ, Peng TI, Yu PZ, Jou SB, Reiter RJ, et al. (2007) Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 43: 389-403.
16. Reiter RJ, Paredes SD, Manchester LC, Tan DX, (2009) Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44: 175-200.
17. Xu SC, He MD, Lu YH, Li L, Zhong M, et al. (2011) Nickel exposure induces oxidative damage to mitochondrial DNA in Neuro2a cells: the neuroprotective roles of melatonin. J Pineal Res 51: 426-433.
18. Kaur C, Sivakumar V, Yong Z, Lu J, Foulds WS, et al. (2007) Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol 212: 429-439.
19. Tosini G, Mensker M, (1998) The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration. Brain Res 789: 221-228.
20. do Carmo Buonfiglio D, Peliciari-Garcia RA, do Amaral FG, Peres R, Nogueira TC, et al. (2011) Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalmol Vis Sci 52: 7416-7422.
21. Ye X, Ren H, Zhang M, Sun Z, Jiang AC, et al. (2012) ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes. Invest Ophthalmol Vis Sci 53: 3481-3489.
22. Riepe RE, Norenburg MD, (1977) Muller cell localisation of glutamine synthetase in rat retina. Nature 268: 654-655.
23. Natesan AK, Cassone VM, (2002) Melatonin receptor mRNA localization and rhythmicity in the retina of the domestic chick Gallus domesticus. Vis Neurosci 19: 265-274.
24. Contreras-Alcantara S, Baba K, Tosini G, (2010) Removal of melatonin receptor type 1 induces insulin resistance in the mouse. Obesity (Silver Spring) 18: 1861-1863.
25. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, et al. (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mellb melatonin receptor. Proc Natl Acad Sci U S A 92: 8734-8738.
26. Ebisawa T, Karne S, Lerner MR, Reppert SM, (1994) Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A 91: 6133-6137.
27. Kensler TW, Wakabayashi N, Biswal S, (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116.
28. Hu R, Saw CL, Yu R, Kong AN, (2010) Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid Redox Signal 13: 1679-1698.
29. Lee SH, Chun W, Kong PJ, Han JA, Cho BP, et al. (2006) Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J Pineal Res 40: 79-85.
30. Kong PJ, Byun JS, Lim SY, Lee JJ, Hong SJ, et al. (2008) Melatonin Induces Akt Phosphorylation through Melatonin Receptor- and PI3K-Dependent Pathways in Primary Astrocytes. Korean J Physiol Pharmacol 12: 37-41.
31. Martín V, Herrera F, Carrera-Gonzalez P, García-Santos G, Antolín I, et al. (2006) Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res 66: 1081-1088.
32. Proietti S, Cucina A, Danselmi F, Dinicola S, Pasqualato A, et al. (2011) Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGF beta-1-dependent growth inhibition of breast cancer cells. J Pineal Res 50: 150-158.
33. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, et al. (2006) Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25: 397-424.
34. Schütte M, Werner P, (1998) Redistribution of glutathione in the ischemic rat retina. Neurosci Lett 246: 53-56.
35. Frasson M, Picaud S, Léveillard T, Simonutti M, Mohand-Said S, et al. (1999) Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci 40: 2724-2734.
36. Oku H, Ikeda T, Honma Y, Sotozono C, Nishida K, et al. (2002) Gene expression of neurotrophins and their high-affinity Trk receptors in cultured human Müller cells. Ophthalmic Res 34: 38-42.
37. Ferrara N, (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611.
38. Bai Y, Ma JX, Guo J, Wang J, Zhu M, et al. (2009) Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol 219: 446-454.
39. Dubocovich ML, Markowska M, (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27: 101-110.
40. Mathes AM, Kubulus D, Weiler J, Bentley A, Waibel L, et al. (2008) Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rat. Crit Care Med 36: 24-29.
41. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, et al. (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 92: 8734-8738.
42. Scher J, Wankiewicz E, Brown GM, Fujieda H, (2002) MT(1) melatonin receptor in the human retina: expression and localization. Invest Ophthalmol Vis Sci 43: 889-897.
43. Das A, McDowell M, Pava MJ, Smith JA, Reiter RJ, et al. (2010) The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-atoxicity involves membrane melatonin receptors. J Pineal Res 48: 157-169.
44. Manning BD, Cantley LC, (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
45. Wang L, Chen Y, Sternberg P, Cai J, (2008) Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest Ophthalmol Vis Sci 49: 1671-1678.
46. Papaiahgari S, Zhang Q, Kleeberger SR, Cho HY, Reddy SP, (2006) Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal 8: 43-52.
47. Seabra ML, Bignotto M, Pinto LR Jr, Tufik S, (2000) Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 29: 193-200.
48. Yi C, Pan X, Yan H, Guo M, Pierpaoli W, (2005) Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci 1057: 384-392.